NEW YORK (MarketWatch) -- Shares of UniQure NV QURE, -two.87% soared 44% in premarket trade Monday, following the gene therapy enterprise announced a collaboration deal with Bristol-Myers Squibb BMY, -.52% which includes Bristol-Myers acquiring an initial...

NEW YORK (MarketWatch) -- Shares of UniQure NV QURE, -two.87% soared 44% in premarket trade Monday, following the gene therapy enterprise announced a collaboration deal with Bristol-Myers Squibb BMY, -.52% which includes Bristol-Myers acquiring an initial equity stake of 4.9% in UniQure. The stake w...